This study shows that two anti-inflammatory compounds, EK100 and antrodin C, selected from components isolated from A. cinnamomea mycelium, can reduce AD-like pathological changes in APP/PS1 mice in different ways when administered orally. The gene discussed is APP; the disease is Alzheimer disease.